Health
A SARS-CoV-2 vaccine candidate based on B.1.351 spike trimer shows broad neutralizing capability – News-Medical.Net
Researchers tested the vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern…
Researchers tested a vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern and the original virus strain.
The emergence of several new mutations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to concerns about increased transmissibility of the virus and the ability of vaccines to protect against them. Some studies point to lower efficacy of vaccines to the new strains compared to…
-
General22 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News21 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News21 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business23 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…